135. アイカルディ症候群
[臨床試験数:1,薬物数:9(DrugBank:3),標的遺伝子数:0,標的パスウェイ数:0]

Searched query = "Aicardi syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2014-002710-23-FR
(EUCTR)
18/06/2015N/AN/A - AGS
MedDRA version: 18.0;Level: PT;Classification code 10054935;Term: Aicardi's syndrome;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
Trade Name: Zidovudine
Product Name: Zidovudine
Product Code: J05A F01
INN or Proposed INN: Zidovudine
Other descriptive name: retrovir
Trade Name: lamivudine
Product Name: lamivudine
Product Code: GX CJ7
INN or Proposed INN: lamivudine
Other descriptive name: epivir
Trade Name: Abacavir
Product Name: Abacavir
Product Code: GX 623
INN or Proposed INN: abacavir
Other descriptive name: ziagen
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)NULLNot RecruitingFemale: yes
Male: yes
24Phase 2France